This study provides initial evidence that dBcAMP-mediated neuroprotection involves the reduction of intracellular copper overload and preservation of mitochondrial integrity, pointing to cuproptosis inhibition as a promising mechanism for future therapeutic exploration.
Cai et al. (Mon,) studied this question.